ConductScience.org, home

Paper26324801

Pulmonary hypertension in patients with chronic myeloproliferative disorders.

Adir Y and 2 others. Eur Respir Rev, 2015. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Pulmonary hypertension in patients with chronic myeloproliferative disorders. Papers, record 26324801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26324801

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pulmonary hypertension in patients with chronic myeloproliferative disorders.
PubMed
Journal
Eur Respir Rev
PubMed
Year
2015
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.44
iCite
Revised in PubMed
2022-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adir YYochai
2Elia DDavide
3Harari SSergio

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arterial PressureMajor topic
Hypertension, PulmonaryMajor topic
Myeloproliferative DisordersMajor topic
Pulmonary ArteryMajor topic
Animals
Antihypertensive Agents
Chronic Disease
Endarterectomy
Humans
Protein Kinase Inhibitors
Risk Assessment
Risk Factors
Thromboembolism
Treatment Outcome

Source PubMed

Download CSV of topics

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117851555Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status.Leukemia2008https://conductscience.org/library/papers/17851555PubMed
216325696Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.Lancet2005https://conductscience.org/library/papers/16325696PubMed
33865532The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases.Am J Hematol1985https://conductscience.org/library/papers/3865532PubMed
419389575
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
J Am Coll Cardiol2009https://conductscience.org/library/papers/19389575PubMed
520530034Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study.Eur Respir J2010https://conductscience.org/library/papers/20530034PubMed
68988890Primary pulmonary hypertension.N Engl J Med1997https://conductscience.org/library/papers/8988890PubMed
717128687Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.J Natl Med Assoc2006https://conductscience.org/library/papers/17128687PubMed
819118230Pulmonary veno-occlusive disease.Eur Respir J2009https://conductscience.org/library/papers/19118230PubMed
99747171Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging.World J Surg1998https://conductscience.org/library/papers/9747171PubMed
1016926298Circulating CD34+ cells, pulmonary hypertension, and myelofibrosis.Blood2006https://conductscience.org/library/papers/16926298PubMed
119387199Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.Semin Thromb Hemost1997https://conductscience.org/library/papers/9387199PubMed
1223614764Pulmonary hypertension in patients with chronic myeloproliferative neoplasms.Leuk Lymphoma2014https://conductscience.org/library/papers/23614764PubMed
131442851Cardiac involvement in patients with myeloproliferative disorders.Am J Med1992https://conductscience.org/library/papers/1442851PubMed
1417110452Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status.Blood2007https://conductscience.org/library/papers/17110452PubMed
1518160817Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.Respiration2008https://conductscience.org/library/papers/18160817PubMed
1611921022Whole-pulmonary low-dose radiation therapy in agnogenic myeloid metaplasia with diffuse lung involvement.Am J Hematol2002https://conductscience.org/library/papers/11921022PubMed
1715781101Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.Lancet2005https://conductscience.org/library/papers/15781101PubMed
188369443Aggregation and disaggregation kinetics of human blood platelets: Part III. The disaggregation under shear stress of platelet aggregates.Biophys J1993https://conductscience.org/library/papers/8369443PubMed
1921719499Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia.Eur Respir J2011https://conductscience.org/library/papers/21719499PubMed
2015585978Severe pulmonary hypertension in chronic idiopathic myelofibrosis.Onkologie2004https://conductscience.org/library/papers/15585978PubMed

See all 76 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42621166Longitudinal prospective analysis of organ stiffness and cardiac function in patients with myelofibrosis treated with ruxolitinib type of study: Prospective single-center cohort study.Ther Adv Hematol2026https://conductscience.org/library/papers/42621166PubMed
41818347Targeting the Hippo pathway in pulmonary arterial hypertension: emerging pharmacological strategies.J Hypertens2026https://conductscience.org/library/papers/41818347PubMed
40257482Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms.Ann Hematol2025https://conductscience.org/library/papers/40257482PubMed
39693509High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera.Blood Adv2025https://conductscience.org/library/papers/39693509PubMed
36700179Combination Therapy With Pulmonary Vasodilatation and JAK2 Inhibition for Pulmonary Hypertension With Polycythemia Vera.CJC Open2023https://conductscience.org/library/papers/36700179PubMed
35420683Patient-specific comorbidities as prognostic variables for survival in myelofibrosis.Blood Adv2023https://conductscience.org/library/papers/35420683PubMed
34900042Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor - a pilot study.Arch Med Sci2021https://conductscience.org/library/papers/34900042PubMed
34545058Chronic Thromboembolic Pulmonary Hypertension Mimicking Acute Pulmonary Embolism: A Case Report.Am J Case Rep2021https://conductscience.org/library/papers/34545058PubMed
34158919Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension.Pulm Circ2021https://conductscience.org/library/papers/34158919PubMed
33785036Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice.J Hematol Oncol2021https://conductscience.org/library/papers/33785036PubMed
33150157The role of genomics and genetics in pulmonary arterial hypertension.Glob Cardiol Sci Pract2020https://conductscience.org/library/papers/33150157PubMed
33024690Successful treatment for a patient with chronic thromboembolic pulmonary hypertension comorbid with essential thrombocythemia with the JAK2 V617F mutation by balloon pulmonary angioplasty.Respir Med Case Rep2020https://conductscience.org/library/papers/33024690PubMed
32700192Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients.Int J Hematol2020https://conductscience.org/library/papers/32700192PubMed
32429621Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients.Blood Res2020https://conductscience.org/library/papers/32429621PubMed
32397294Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.Int J Mol Sci2020https://conductscience.org/library/papers/32397294PubMed
31918690Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report.BMC Pulm Med2020https://conductscience.org/library/papers/31918690PubMed
31695170Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis.Bone Marrow Transplant2020https://conductscience.org/library/papers/31695170PubMed
30896614Pulmonary hypertension with massive megalosplenia: A case report.Medicine (Baltimore)2019https://conductscience.org/library/papers/30896614PubMed
30149506Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension.Int J Mol Sci2018https://conductscience.org/library/papers/30149506PubMed
30081463Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.Int J Mol Sci2018https://conductscience.org/library/papers/30081463PubMed

See all 27 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26324801

GET https://conductscience.org/api/papers/v1/26324801/references?page=2